Czechia vs Montenegro: Colon and rectum cancer screening coverage in Europe
Czechia
31.1%
in 2024
Montenegro
22.7%
in 2024
Czechia rank
14th
Montenegro rank
17th
Colon and rectum cancer screening coverage in Europe over time
- Czechia
- Montenegro
How they compare
Czechia currently reports 31.1% against 22.7% in Montenegro, a difference of 8.4%.
That makes Czechia's figure about 1.4 times Montenegro's.
Across all 6 years both countries report, Czechia has been ahead every year.
Czechia ranks 14th and Montenegro ranks 17th of 20 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 30.0% | 23.7% | 6.3% | Czechia |
| 2020s | 28.8% | 9.7% | 19.1% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Czechia or Montenegro?
- Czechia, at 31.1% against 22.7% in Montenegro as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Czechia and Montenegro?
- 8.4%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Montenegro?
- 6 years are reported by both, from 2019 to 2024.
- How do Czechia and Montenegro rank globally for colon and rectum cancer screening coverage in europe?
- Czechia ranks 14th and Montenegro ranks 17th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.